Drug-Likeness Beyond Lipinski: Rethinking Natural Product Developability Through Bioavailability, Structural Complexity, Formulation Feasibility, and Safety Logic
International Journal of Pharmaceutical And Phytopharmacological Research · 2025 · 15 (4) · 12-20
DOI: 10.51847/lx1ewvcmku ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical And Phytopharmacological Research, 2025. Verfasst von Krzysztof Wiśniewski und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wiśniewski, K., Nowak, M., & Adamczyk, T. (2025). Drug-Likeness Beyond Lipinski: Rethinking Natural Product Developability Through Bioavailability, Structural Complexity, Formulation Feasibility, and Safety Logic. International Journal of Pharmaceutical And Phytopharmacological Research, 15(4), 12-20. https://doi.org/10.51847/lx1ewvcmku
Vancouver
Wiśniewski K, Nowak M, Adamczyk T. Drug-Likeness Beyond Lipinski: Rethinking Natural Product Developability Through Bioavailability, Structural Complexity, Formulation Feasibility, and Safety Logic. International Journal of Pharmaceutical And Phytopharmacological Research. 2025;15(4):12-20. doi:10.51847/lx1ewvcmku
BibTeX
@article{Winiewski2025,
author = {Wiśniewski, Krzysztof and Nowak, Małgorzata and Adamczyk, Tomasz},
title = {Drug-Likeness Beyond Lipinski: Rethinking Natural Product Developability Through Bioavailability, Structural Complexity, Formulation Feasibility, and Safety Logic},
journal = {International Journal of Pharmaceutical And Phytopharmacological Research},
year = {2025},
volume = {15},
number = {4},
pages = {12--20},
doi = {10.51847/lx1ewvcmku}
}
EUVIMED